MAPT and proteostasis deficiencies: Nonetheless, our data evidence positive cardiovascular‐related associations across genotypes reflecting both tau and TAR DNA‐binding protein 43 (TDP‐43) proteinopathies, suggesting benefits of systemic cardiovascular health in FTLD may not be specific to one type of proteinopathy.